- Home
- NUWE vs QNRX Comparison
NUWE vs QNRX Comparison
Compare NUWE & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- QNRX
- Stock Information
- Founded
- NUWE 1999
- QNRX 2018
- Country
- NUWE United States
- QNRX United States
- Employees
- NUWE N/A
- QNRX N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- QNRX Medical/Dental Instruments
- Sector
- NUWE Health Care
- QNRX Health Care
- Exchange
- NUWE Nasdaq
- QNRX Nasdaq
- Market Cap
- NUWE 3.9M
- QNRX 3.3M
- IPO Year
- NUWE N/A
- QNRX N/A
- Fundamental
- Price
- NUWE $0.23
- QNRX $9.60
- Analyst Decision
- NUWE Strong Buy
- QNRX
- Analyst Count
- NUWE 1
- QNRX 0
- Target Price
- NUWE $17.00
- QNRX N/A
- AVG Volume (30 Days)
- NUWE 30.9M
- QNRX 12.9K
- Earning Date
- NUWE 08-12-2025
- QNRX 08-07-2025
- Dividend Yield
- NUWE N/A
- QNRX N/A
- EPS Growth
- NUWE N/A
- QNRX N/A
- EPS
- NUWE N/A
- QNRX N/A
- Revenue
- NUWE $8,787,000.00
- QNRX N/A
- Revenue This Year
- NUWE $6.53
- QNRX N/A
- Revenue Next Year
- NUWE $51.63
- QNRX N/A
- P/E Ratio
- NUWE N/A
- QNRX N/A
- Revenue Growth
- NUWE N/A
- QNRX N/A
- 52 Week Low
- NUWE $0.21
- QNRX $5.01
- 52 Week High
- NUWE $6.61
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- NUWE 26.12
- QNRX 64.78
- Support Level
- NUWE $0.21
- QNRX $8.04
- Resistance Level
- NUWE $0.32
- QNRX $8.58
- Average True Range (ATR)
- NUWE 0.07
- QNRX 0.46
- MACD
- NUWE 0.00
- QNRX 0.04
- Stochastic Oscillator
- NUWE 11.43
- QNRX 98.57
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.